Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)

Autor: Lee, Tetz C, Qian, Min, Lip, Gregory YH, Di Tullio, Marco R, Graham, Susan, Mann, Douglas L, Nakanishi, Koki, Teerlink, John R, Freudenberger, Ronald S, Sacco, Ralph L, Mohr, JP, Labovitz, Arthur J, Ponikowski, Piotr, Lok, Dirk J, Estol, Conrado, Anker, Stefan D, Pullicino, Patrick M, Buchsbaum, Richard, Levin, Bruce, Thompson, John LP, Homma, Shunichi, Ye, Siqin, WARCEF Investigators

Publikováno v: The American journal of cardiology, vol 122, iss 5

Previous studies in patients with atrial fibrillation showed that a history of heart failure (HF) could negatively impact anticoagulation quality, as measured by the average time in therapeutic range (TTR). Whether additional markers of HF severity a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::6339a979283c373ed6bebc6f54748cbe
https://escholarship.org/uc/item/3gw7b4dd

Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial

Autor: Di Tullio, Marco R, Qian, Min, Thompson, John LP, Labovitz, Arthur J, Mann, Douglas L, Sacco, Ralph L, Pullicino, Patrick M, Freudenberger, Ronald S, Teerlink, John R, Graham, Susan, Lip, Gregory YH, Levin, Bruce, Mohr, JP, Buchsbaum, Richard, Estol, Conrado J, Lok, Dirk J, Ponikowski, Piotr, Anker, Stefan D, Homma, Shunichi, WARCEF Investigators

Publikováno v: Stroke, vol 47, iss 8

Background and purposeIn heart failure (HF), left ventricular ejection fraction (LVEF) is inversely associated with mortality and cardiovascular outcomes. Its relationship with stroke is controversial, as is the effect of antithrombotic treatment. We

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::5f5d9d5692fd396bdce2d4cd5ec27f65
https://escholarship.org/uc/item/5k52n1j5

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy

Autor: Homma, Shunichi, Thompson, John LP, Qian, Min, Ye, Siqin, Di Tullio, Marco R, Lip, Gregory YH, Mann, Douglas L, Sacco, Ralph L, Levin, Bruce, Pullicino, Patrick M, Freudenberger, Ronald S, Teerlink, John R, Graham, Susan, Mohr, JP, Labovitz, Arthur J, Buchsbaum, Richard, Estol, Conrado J, Lok, Dirk J, Ponikowski, Piotr, Anker, Stefan D, WARCEF Investigators

Publikováno v: Circulation. Heart failure, vol 8, iss 3

BackgroundThe aim of this study is to examine the relationship between time in the therapeutic range (TTR) and clinical outcomes in heart failure patients in sinus rhythm treated with warfarin.Methods and resultsWe used data from the Warfarin versus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::abbff35340d565cf687136ec83e6b594
https://escholarship.org/uc/item/2f75m4h6

Populationsbasierte Studie zu Ätiologie und Prognose von erstmaligen ischämischen Insulten im vertebrobasilären versus Carotisstromgebiet

Autor: Khaw, AV, Rundek, T, Lee, HS, Stapf, C, Schumacher, HC, Mast, H, Mohr, JP, Sacco, RL

Publikováno v: Aktuelle Neurologie; 20240101, Issue: Preprints

William L. Young, MD August 6, 1954, to August 1, 2013 In Memoriam

Autor: Mohr, JP, Kim, H, Pawlikowska, L, Su, H

Publikováno v: STROKE, vol 45, iss 1
Mohr, JP; Kim, H; Pawlikowska, L; & Su, H. (2014). William L. Young, MD August 6, 1954, to August 1, 2013 In Memoriam. STROKE, 45(1), 2-3. doi: 10.1161/STROKEAHA.113.003230. UCSF: Retrieved from: http://www.escholarship.org/uc/item/1540s3c8

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::50d88894af97164364c59fa4cfef8084
https://escholarship.org/uc/item/1540s3c8